GILEAD SCIENCES INC (GILD) - Price, trends, fundamentals and chart - Passport to Wall Street

GILEAD SCIENCES INC (NASDAQ: GILD)

Overview

current price

$117.41

$117.41

change

1.37 | 1.18%

1.37 | 1.18%

Yesterday's Close

116.04

open

115.65

volume

5.74 M

30d. avg volume.

8.35 M

1 day

114.79 - 117.74

52 weeks

62.07 - 117.39

p/e

305.37

beta

0.2237

market cap

144.51 B

dividend yield

2.72%

Industry

-

News and Commentary

Market Update: Dow Rises 100 Points as Powell Continues Cautious Tone on Interest Rates Stocks were little changed Tuesday as market participants reacted to a cautious tone on interest rates from Federal Reserve Chair Jerome Powell. The Dow Jones Industrial Average...

Market Update: Dow Falls 700 Points on Hot December Jobs Report Stocks fell on Friday as December's red hot jobs report dashed investor expectations for more interest rate cuts this year. The Dow Jones Industrial Average dropped nearly 700 po...

Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing... Thursday, Gilead Sciences, Inc. (

Market Update: Dow Climbs 200 Points on Another In-Line Inflation Report Stocks rose Thursday as investors continued to buy the dip in tech stocks ahead of the Federal Reserve's policy meeting next week. The Dow Jones Industrial Average rose over 200...

Market Update: Dow Rallies 680 Points, S&P 500 Posts Best Day in Nearly Two Years Stocks rose higher Thursday as new labor market data lessened growing fears of an imminent recession from earlier in the week. The Dow Jones Industrial Average rallied over 680 p...

Market Update: S&P 500 Briefly Passes 5,500, Dow Climbs 300 Points on Nvidia Market Strength The S&P 500 Index briefly rose above 5,500 for the first time ever on Thursday as Nvidia's

Market Update: Dow Closes Above 38,000 First Time, S&P 500 Sets New All-Time High Stocks rose to record levels on Monday as investors continued to build on Wall Street's recent momentum. The Dow Jones Industrial Average climbed nearly 140 points to close above...

AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains AbbVie Inc (ABBV ...

Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions Gilead Sciences Inc (GILD

Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increa... Pfizer Inc (PFE

StockTwits

StockTwits